APA aipamena

Picard, N., Rouguieg-Malki, K., Kamar, N., Rostaing, L., & Marquet, P. (2011). CYP3A5 genotype does not influence everolimus in vitro metabolism and clinical pharmacokinetics in renal transplant recipients. Lippincott Williams & Wilkins.

Chicago Style aipamena

Picard, Nicolas, Koukeb Rouguieg-Malki, Nassim Kamar, Lionel Rostaing, and Pierre Marquet. CYP3A5 Genotype Does Not Influence Everolimus in Vitro Metabolism and Clinical Pharmacokinetics in Renal Transplant Recipients. Lippincott Williams & Wilkins, 2011.

MLA aipamena

Picard, Nicolas, et al. CYP3A5 Genotype Does Not Influence Everolimus in Vitro Metabolism and Clinical Pharmacokinetics in Renal Transplant Recipients. Lippincott Williams & Wilkins, 2011.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.